Skip to main content

Table 3 Medication Possession Rates (MPR) and Clinical Characteristics

From: Persistence and compliance to antidepressant treatment in patients with depression: A chart review

 

MPR (mean ± SD)

Any antidepressant (n = 367)

0.77 ± 0.28

Initial antidepressant

0.71 ± 0.31

   Sulpiride (n = 148)

0.72 ± 0.28

   Paroxetine (n = 114)

0.70 ± 0.35

   Fluvoxamine(n = 34)

0.64 ± 0.30

   Sertraline(n = 33)

0.77 ± 0.28

   Milnacipran(n = 31)

0.78 ± 0.30

   Amoxapine (n = 5)

0.64 ± 0.27

   Trazodone (n = 2)

0.68 ± 0.64

 

MPR of any antidepressant

Sex a

 

   Female (n = 197)

0.73 ± 0.29

   Male (n = 170)

0.81 ± 0.26

Age group b

 

   Before age 40 (n = 241)

0.76 ± 0.28

   40–59 (n = 95)

0.76 ± 0.25

   60 or older(n = 31)

0.87 ± 0.29

Anxiolytics use

 

   No (n = 245)

0.77 ± 0.29

   Yes (n = 122)

0.77 ± 0.25

Hypnotics use

 

   No (n = 191)

0.78 ± 0.29

   Yes (n = 176)

0.76 ± 0.27

  1. aUnivariate general linear model found that gender had significant effects on the MPR (F(1,343) = 4.43; Corrected Model: F(23,343) = 1.78, p = 0.016, R2 = 0.11).
  2. b Univariate general linear model found that age group had significant effects on the MPR (F(2,343) = 3.39, p = 0.035; Corrected Model: F(23,343) = 1.78, p = 0.016, R2 = 0.11).
Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us